The No1 Ethical retailer for Books, CD’s, DVD’s & Games
30 Day Refund Guarantee

The Commercial Use of Biodiversity: Access to Genetic Resources and Benefit Sharing

The Commercial Use of Biodiversity: Access to Genetic Resources and Benefit Sharing

by SarahA.Laird (Author), KerryTenKate (Author)

  • Used

    Hardcover 1999

    $6.77
Synopsis

In this authoritative and comprehensive volume the authors explain the provisions of the Convention on Biological Diversity on access and benefit-sharing, the effect of national laws to implement these, and aspects of typical contracts for the transfer of materials. They provide a unique sector-by-sector analysis of how genetic resources are used, the scientific, technological and regulatory trends and the different markets in Pharmaceuticals, Botanical Medicines, Crop Development, Horticulture, Crop Protection, Biotechnology (in fields other than healthcare and agriculture) and Personal Care and Cosmetics Products. This will be an essential sourcebook for all those in the commercial chain, from raw material collection to product discovery, development and marketing, for governments and policy-makers drafting laws on access and for all the institutions, communities and individuals involved in the conservation, use, study and commercialisation of genetic resources.

$6.77

Save:$87.24 (93%)

Quantity

1 in stock

More Information

Format: Hardcover
 Pages: 398
 Publisher: Earthscan Ltd
Published: 01 Aug 1999
ISBN 10: 1853833347
ISBN 13: 9781853833342

Media Reviews
'Written by two of the world's leading authorities on the commercial use of biodiversity, this book is an invaluable resource and guide for further research. It is as practical as it is informative and should be in the hands of everyone interested in the state and fate of the world's living resources' Professor Calestous Juma, Harvard University 'Full of examples from which we can learn... this will be an invaluable resource to policy-makers, organizations studying and creating uses for genetic resources and the companies which wish to develop them' from the Foreword by Professor Sir Ghillean Prance, ex-Director, Kew Gardens and Sir Richard Sykes, ex-Chairman, Glaxo Wellcome
Author Bio
Kerry ten Kate is Policy Adviser for the Directorate of, and Sarah Laird is Independent Consultant for the Convention on Biodiversity Unit at, the Royal Botanic Gardens, Kew